logo

Biotech Stocks Facing FDA Decision In October 2019

Pending Drug Approvals
Pending Drug Approvals

So far this year, 27 novel drugs have been approved compared to 41 during the same period last year.

2018 holds the record for the maximum number of new drug approvals – with 59 drugs compared to 46 in 2017. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Now, let's take a look at the companies that await a ruling from the FDA in October 2019.

Share



>